Results 11 to 20 of about 195,292 (253)

Laudato Si’: a bridge towards access to medicines

open access: yesVigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia, 2018
Pope Francis’ Encyclical Laudato Si’, albeit not explicitly, has drawn attention worldwide to the access to medicines as a fundamental human right, as it raises awareness about the current situation of the world and the poor.
Jorge Antonio Zepeda Bermudez   +6 more
doaj   +7 more sources

Signal of harm in morphine use in adults with acute pulmonary oedema: A rapid systematic review

open access: yesSouth African Medical Journal, 2023
Background. Heart failure affects nearly 65 million people globally, resulting in recurrent hospital admissions and substantial healthcare expenditure.
C Hendrikse   +6 more
doaj   +1 more source

Essential tuberculosis medicines and health outcomes in countries with a national essential medicines list

open access: yesJournal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2022
Background: Tuberculosis (TB) remains a major cause of morbidity and mortality globally despite effective treatments. Along with high-quality health services, essential medicines are a key tool in curbing TB related mortality.
Darshanand Maraj   +2 more
doaj   +1 more source

Implementation of health technology assessment at the stage of market access for pharmaceuticals in Ukraine

open access: yesФармацевтичний журнал, 2020
Market access for pharmaceuticals is a set of strategies, activities and processes developed by pharmaceutical companies to provide affordable medicines at appropriate fair prices in a particular health care system.
O. B. Piniazhko   +5 more
doaj   +1 more source

THE ESSENTIAL OF THE ART OF MEDICINE. [PDF]

open access: yesJAMA: The Journal of the American Medical Association, 1898
The closing years of the eighteenth century and the early years of the nineteenth century marked an epoch in medicine as transcendent for its welfare as the events of the past decade bespeak for the glory of the medicine of the future. In that epoch was witnessed the passing of the old; the dawn of the new.
openaire   +1 more source

New diagnostics for tuberculosis: fulfilling patient needs first

open access: yesJournal of the International AIDS Society, 2010
Background An effective tuberculosis (TB) control programme requires early diagnosis and immediate initiation of treatment. Any delays in diagnosing TB not only impair a patient's prognosis, but also increase the risks of transmitting the disease within ...
Jean‐François Lemaire   +1 more
doaj   +1 more source

Promoting transparency, accountability, and access through a multi-stakeholder initiative: lessons from the medicines transparency alliance

open access: yesJournal of Pharmaceutical Policy and Practice, 2017
Background Barriers to expanding access to medicines include weak pharmaceutical sector governance, lack of transparency and accountability, inadequate attention to social services on the political agenda, and financing challenges.
Taryn Vian   +3 more
doaj   +1 more source

Institutionalizing Health Technology Assessment in South Africa—An Opportunity in National Health Insurance

open access: yesHealth Systems & Reform, 2023
While South Africa has some experience in various forms of health technology assessment (HTA), it is currently fragmented across numerous players. Additionally, there is a lack of systematic and consistently applied HTA processes that inform priority ...
Janine Jugathpal   +4 more
doaj   +1 more source

One or two serological assay testing strategy for diagnosis of HBV and HCV infection? The use of predictive modelling

open access: yesBMC Infectious Diseases, 2017
Background Initial serological testing for chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infection is conducted using either rapid diagnostic tests (RDT) or laboratory-based enzyme immunoassays (EIA)s for detection of hepatitis B surface ...
John V. Parry   +2 more
doaj   +1 more source

Implementing essential diagnostics-learning from essential medicines: A scoping review.

open access: yesPLOS Global Public Health, 2022
The World Health Organization (WHO) model list of Essential In vitro Diagnostic (EDL) introduced in 2018 complements the established Essential Medicines List (EML) and improves its impact on advancing universal health coverage and better health outcomes.
Moriasi Nyanchoka   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy